Pipecolic acid
|
Basic information |
| Metabolite name | Pipecolic acid |
 | HMDB0000070 |
 |
C00408 |
 |
849 |
| Synonyms | L-Pipecolic acid; |
| No. of studies | 20 |
|
Basic information |
| Metabolite name | Pipecolic acid |
| HMDB0000070 |
|
C00408 |
|
849 |
| Synonyms | L-Pipecolic acid; |
| No. of studies | 20 |
|
Relationship between Pipecolic acid and depression (count: 20) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M050 | Type3 | 14h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M074 | Type1 | sCSDS group vs. control group | Faece | C57BL/6JJmsSlc mouse | Up |
| Study M1105 | Type1 | psychological stress group vs. control group | Faece | C57BL/6 J mouse | Down |
| Study M204 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Down |
| Study M480 | Type1 | sleep deprivation group vs. control group | Urine | Wistar rat | Down |
| Study M541 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M556 | Type1 | sleep deprivation group vs. control group | Urine | Wistar rat | Down |
| Study M571 | Type1 | LPS group vs. control group | Hypothalamus | CD-1 mouse | Down |
| Study M578 | Type1 | restraint stress offspring group vs. control offspring group | Hippocampus | Sprague-Dawley rat | Up |
| Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, validation cohort | Plasma | Human | Down |
| Study M676 | Type1 | CVS group vs. control group | Hippocampus | Wistar rat | Down |
| Study M676 | Type2 | CVS + Chaihu-Shu-Gan-San group vs. CVS group | Hippocampus | Wistar rat | Up |
| Study M690 | Type2 | CUMS + high dose of Zhi-zi-chi decoction group vs. CUMS group | Serum | Balb/c mouse | Up |
| Study M691 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M691 | Type2 | CUMS + low dose of Chaihu-Baishao group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M691 | Type2 | CUMS + low dose of Chaihu group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M715 | Type1 | MDD group vs. control group | Faece | Human | Down |
| Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Up |
| Study M838 | Type1 | MS + stranger group vs. control group | Faece | Wistar rat | Down |
| Study M838 | Type1 | MS group vs. control group | Faece | Wistar rat | Down |
| Study M838 | Type2 | MS + stranger + Lactobacillus paracasei group vs. MS + stranger group | Faece | Wistar rat | Up |
| Study M838 | Type2 | MS + Lactobacillus paracasei group vs. MS group | Faece | Wistar rat | Up |
| Study M846 | Type1 | postpartum depression model group vs. control group | Faece | BALB/c mouse | Up |
| Study M867 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M867 | Type2 | CUMS + Baihe-Dihuang Tang group vs. CUMS group | Plasma | Sprague-Dawley rat | Unknown |
| Study M924 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M924 | Type2 | CUMS + aerobic exercise group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |